dsta4637s
mAbexperimentalADC
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2015 (NCT02596399)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Staphylococcus aureusImmunity, passive
Staphylococcus aureus immunity, passive
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- dmDNA31
Oral
No
Parenteral
No
Topical
No
Also known as
- dsta4637s
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03162250 | Phase 1 | May 31, 2017 | Genentech |
| NCT02596399 | Phase 1 | Nov 30, 2015 | Genentech, Roche |
Showing 2 of 2 trials
Page 1 / 1